[Dose-response comparison with etiroxat HCl in hyperlipoproteinemias types IIa and IIb].
D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D008297:Male; D013974:Thyroxine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000924:Anticholesteremic Agents; C010150:etiroxate; D013974:Thyroxine
Dosis-Wirkungs-Vergleich mit Etiroxat-HCl bei Hyperlipoproteinämien vom Typ IIa und IIb.